UCB's Global Corporate Website
Welcome to UCB in the United States
UCB_TickingNumbers_Resize_Body

Sep

24

Clinical Research 101

Whether it is discovering a therapy that could work for an individual patient faster or finding new ways to treat the root cause of a disease, at UCB, we are committed to continuing to unlock the science to improve the lives of patients.

Blog_Photo_1280x960

Sep

20

ICYMI: UCB in the News

At UCB, we strive to discover and deliver new solutions patients value. Whether it’s through leveraging big data, thinking outside the box to overcome barriers, or collaborating with others in the healthcare industry—initiatives across UCB are at the forefront of research, and recently, our experts have been in the news talking about what we’re working on.

new_Epilepsy_Family_Scholarship_Sized_1280x960

Sep

11

Announcing the 2018 UCB Family Epilepsy Scholarship Winners

UCB is pleased to announce 32 recipients were awarded the 2018 UCB Family Epilepsy Scholarship. This year’s winners are beginning their academic year at 31 schools across the country where awards will support their undergraduate or graduate education. Hailing from 17 states, this diverse group of passionate advocates includes people living with epilepsy or caregiving for someone living with epilepsy, including parents and siblings.

Maria_Genco_31280x960

Sep

05

Where is She Now? Reflections from UCB’s First Scholarship Winner

As one of the first winners of the UCB Family Epilepsy Scholarship, Maria reflects on the goals, choices, and experiences that have shaped her ever-evolving career in science.

Alisha_Bridges_1280x960

Aug

29

The Day Psoriasis Stopped Stopping Me

As part of Psoriasis Action Month, Alisha Bridges, an award-winning writer and community advocate, recently shared her story about living with psoriasis.

9q0ipi0055

Aug

23

UCB Runners Lace Up to Support Patients

UCB supports local events across the country that benefit patients. Recently, our employees participated in two different runs in support of the epilepsy and Crohn’s disease communities.

Aug

13

Press Release: FDA Accepts New Drug Application (NDA) to review Midazolam Nasal Spray, an investigational product for the acute treatment of seizure clusters

FDA Accepts New Drug Application (NDA) to review Midazolam Nasal Spray, an investigational product for the acute treatment of seizure clusters

MHT_Spondylitis_Webpage_1280v960_for_Blog

Aug

08

New Resource for Those Living with Spondyloarthritis

An estimated 3.3 million individuals in the U.S. are living with spondyloarthritis1,2 (SpA), an inflammatory disease affecting the spine, and in some people, the joints of the arms and legs, skin, intestines, and eyes. An underdiagnosed condition, most people with SpA first experience symptoms in their 20s or 30s but typically wait as many as 10 years between symptom onset and SpA diagnosis. * 

PsO_Patient_1280x960

Aug

01

Disease Spotlight: Psoriasis

August is Psoriasis Awareness Month so we’re shining a spotlight on the disease and how UCB is working to deliver solutions that patients value. 

Travel_post_1280x960

Jul

27

Resources for Traveling with a Chronic Illness

At UCB, we strive to support patients to live their best lives possible, and we know getting time away from home for summer vacation or other travel needs is part of life. Whether you live with a chronic illness, are a caregiver for someone who lives with a chronic illness, or not - traveling can be stressful. However, for many people living with a chronic illness, special considerations are needed during travel, and it can be particularly challenging when you must travel with medicines. Fortunately, with a little planning, you can decrease the hassle, reduce your stress, and enjoy your trip.